Evidence map›Paper›PMID 25929882›Full record

ArticleAJNR. American journal of neuroradiology2015

The Role of Core Needle Biopsy and Its Impact on Surgical Management in Patients with Medullary Thyroid Cancer: Clinical Experience at 3 Medical Institutions.

E J Ha, J H Baek, D G Na, J-h Kim, J K Kim, H S Min, D E Song, K E Lee, Y K Shong

Open access · hybridAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Recent Advances in Core Needle Biopsy for Thyroid Nodules.Endocrinology and metabolism (Seoul, Korea) · 2017
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

E J HaFrom the Department of Radiology and the Research Institute of Radiology (E.J.H., J.H.B) Department of Radiology (E.J.H.), Ajou University School of Medicine, Suwon, Korea.
J H BaekFrom the Department of Radiology and the Research Institute of Radiology (E.J.H., J.H.B) radbaek@naver.com.
D G NaDepartment of Radiology (D.G.N.), Human Medical Imaging and Intervention Center, Seoul, Korea Healthcare System Gangnam Center (D.G.N.), Seoul National University Hospital, Seoul, Korea.
J-h KimDepartments of Radiology (J.-h.K.).
J K KimDepartment of Radiology (J.K.K.), Chung-Ang University College of Medicine, Seoul, Korea.
H S MinPathology (H.S.M.).
D E SongDepartments of Pathology (D.E.S.).
K E LeeSurgery (K.E.L.), Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Y K ShongMetabolism and Endocrinology (Y.K.S.), University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Seoul National University Hospital · KRAjou University · KRApath (United States) · USAsan Medical Center · KRResearch Institute of Radiology · BY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeMedullary thyroid carcinoma is an uncommon malignancy that is challenging to diagnose. Our aim was to present our experience using core needle biopsy for the diagnosis of medullary thyroid carcinoma compared with fine-needle aspiration. MATERIALS AND

methodsBetween January 2000 and March 2012, 202 thyroid nodules in 191 patients were diagnosed as medullary thyroid cancer by using sonography-guided fine-needle aspiration, core needle biopsy, or surgery. One hundred eighty-three thyroid nodules in 172 patients were included on the basis of the final diagnosis. We evaluated the sensitivity and positive predictive value of fine-needle aspiration and core needle biopsy for the diagnosis of medullary thyroid cancer. We compared the rate of a delayed diagnosis, a diagnostic surgery, and surgery with an incorrect diagnosis for fine-needle aspiration and core needle biopsy and investigated the factors related to the fine-needle aspiration misdiagnosis of medullary thyroid cancer.

resultsFine-needle aspiration showed 43.8% sensitivity and 85.1% positive predictive value for the diagnosis of medullary thyroid cancer; 25.7% (44/171) of patients had a delayed diagnosis, while 18.7% (32/171) underwent an operation for accurate diagnosis, and 20.5% (35/171) underwent an operation with an incorrect diagnosis. Core needle biopsy achieved 100% sensitivity and positive predictive value without a delay in diagnosis (0/22), the need for a diagnostic operation (0/22), or an operation for an incorrect diagnosis (0/22). A calcitonin level of <100 pg/mL was the only significant factor for predicting the fine-needle aspiration misdiagnosis of medullary thyroid cancer (P = .034).

conclusionsCore needle biopsy showed a superior sensitivity and positive predictive value to fine-needle aspiration and could optimize the surgical management in patients with medullary thyroid cancer. Because the ability of fine-needle aspiration to diagnose medullary thyroid cancer significantly decreases in patients with serum calcitonin levels of <100 pg/mL, core needle biopsy could be indicated for these patients to optimize their surgical management.

Indexed as

Biopsy, Large-Core NeedleAdultAgedBiopsy, Fine-NeedleCarcinoma, NeuroendocrineDiagnostic ErrorsFemaleHumansMaleMiddle AgedSensitivity and SpecificityThyroid NeoplasmsThyroid Nodule

Identifiers

PMID25929882
PMCPMC7964688
OpenAlexW2324917908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.